[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

Know Your Myeloma Immunotherapy: Bispecific Antibodies with Dr. Cesar Rodriguez

Know Your Myeloma Immunotherapy: Bispecific Antibodies with Dr. Cesar Rodriguez image

Know Your Myeloma Immunotherapy: Bispecific Antibodies with Dr. Cesar Rodriguez

Webinar
event Jun 23, 2022 / 07:00PM - 08:00PM EDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Bispecific antibodies have the potential to change myeloma treatment forever. Get to know this exciting immunotherapy. There are many bispecific antibodies being tested in clinical trials and awaiting FDA approval. What are some of their mechanisms of action? What is their potential in treating myeloma? Come with your questions and learn with us.

Schedule & Agenda

Event panelist Audrey Burton-Bethkee
07:00 PM
Introduction
Audrey Burton-Bethkee
Audrey introduces the agenda of the event and featured speaker Dr. Cesar Rodriguez.
Event panelist Dr. Cesar Rodriguez
07:05 PM
Presentation
Dr. Cesar Rodriguez
Dr. Rodriguez talks about how bispecific antibodies have the potential to change myeloma treatment forever.
Event panelist Audience
07:35 PM
Questions and Answers
Audience
Type your questions in the chat and we will answer them!

Speakers & Moderators

The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio
The panelist Cesar Rodriguez, MD
Cesar Rodriguez, MD

Dr. Cesar Rodriguez is Associate Professor of Medicine at the Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, and the Center of Excellence for Multiple Myeloma, and serves as Clinical Director of Multiple Myeloma at The Mount Sinai Hospital. Dr. Rodriguez has extensive experience treating patients with plasma cell disorders. He is a member of the International Myeloma Working Group which conducts collaborative research and produces consensus guidelines for the myeloma community. Dr. Rodriguez has more than 10 years of experience in clinical research and is the principal investigator of numerous clinical trials for multiple myeloma focused on early drug development and immunotherapies that include T cell and NK cell directed therapies. He is also working on a 3D organoid model to better understand the biology of the tumor niche.

Read Bio
HealthTree Connect Icon

Join the Conversation

This event is part of the Treatment & Testing group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Adaptive logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.